Remedy Pharmaceuticals logo

Remedy Pharmaceuticals jobs and careers

New York, NY, United States

About Remedy Pharmaceuticals

Remedy Pharmaceuticals, Inc. develops small molecule drugs that target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes, and spinal cord injuries. Its RP-1127 is an intravenous version of glyburide, an inhibitor of NCCa-ATP channels that acts through antagonism of the type-1 sulfonylureareceptor. The company was founded in 2004 and is based in New York, New York.

Founded in 2004 by David M. Geliebter and Sven M. Jacobson.

Founded
2004
Employees
11 to 50
Total funding
$18.5M
Headquarters
New York

Leadership

The top of Remedy Pharmaceuticals's org chart, with how many people report into each leader.

SJPhoto of Sven Jacobson

Sven Jacobson

CEO/Cofounder

2 reports

TP

Thomas MacAllister, JD, PhD

Vice President of R&D and General Counsel

AT

Ann Tunstall

Vice President, Regulatory and Clinical Operations